Stay updated on Dose Dense Paclitaxel with Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page.

Latest updates to the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page
- CheckyesterdayChange DetectedRelated topics in the study page were trimmed by removing 'Ovarian cancer' and 'MedlinePlus Genetics', reducing the navigational links presented on the page.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, signaling an underlying platform update rather than a change to the study content.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page now includes institutional identifiers and a 'Helpful Links Provided by' section, referencing the Moffitt Cancer Center and its Clinical Trials website.SummaryDifference0.2%

- Check30 days agoChange DetectedAdded a disease tag 'Ovarian cancer' and a 'MedlinePlus Genetics' related topics link to the page, improving navigation and connecting the study to consumer health information related to ovarian cancer and genetics. These additions help users connect the study to related topics about ovarian cancer and genetics.SummaryDifference0.2%

- Check37 days agoChange DetectedSite revision tag updated to Revision: v3.6.5. Non-core glossary topics and the previous revision entry were removed from the related topics area.SummaryDifference0.2%

- Check51 days agoChange DetectedOvarian cancer was added as a topic, and related topics now include MedlinePlus Genetics. The site revision version was updated from 3.6.3 to 3.6.4.SummaryDifference0.2%

Stay in the know with updates to Dose Dense Paclitaxel with Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page.